Jonathan David Herman, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Immunization, Passive | 2 | 2022 | 616 | 0.830 |
Why?
|
Malaria, Falciparum | 5 | 2024 | 1077 | 0.790 |
Why?
|
Immunity, Humoral | 2 | 2023 | 606 | 0.790 |
Why?
|
Plasmodium falciparum | 6 | 2024 | 1742 | 0.680 |
Why?
|
Antimalarials | 4 | 2019 | 907 | 0.620 |
Why?
|
Amino Acyl-tRNA Synthetases | 2 | 2019 | 88 | 0.620 |
Why?
|
Plasma | 1 | 2021 | 586 | 0.610 |
Why?
|
Quinazolinones | 3 | 2019 | 221 | 0.570 |
Why?
|
Antibodies, Viral | 3 | 2023 | 3156 | 0.540 |
Why?
|
Rheumatic Diseases | 1 | 2023 | 649 | 0.540 |
Why?
|
Immunity | 1 | 2021 | 996 | 0.510 |
Why?
|
Protozoan Proteins | 3 | 2019 | 847 | 0.500 |
Why?
|
Drug Resistance | 4 | 2019 | 1596 | 0.490 |
Why?
|
Naphthyridines | 1 | 2013 | 143 | 0.400 |
Why?
|
Nucleocapsid | 2 | 2022 | 63 | 0.400 |
Why?
|
Plasmodium | 1 | 2013 | 246 | 0.350 |
Why?
|
Piperidines | 3 | 2019 | 1656 | 0.350 |
Why?
|
Quinazolines | 1 | 2015 | 1371 | 0.310 |
Why?
|
Biological Evolution | 1 | 2014 | 1071 | 0.300 |
Why?
|
Enzyme Inhibitors | 1 | 2015 | 3713 | 0.230 |
Why?
|
Endemic Diseases | 1 | 2023 | 190 | 0.200 |
Why?
|
Malaria Vaccines | 1 | 2024 | 165 | 0.200 |
Why?
|
Liver | 2 | 2015 | 7529 | 0.190 |
Why?
|
Malaria | 2 | 2023 | 1227 | 0.180 |
Why?
|
Receptors, Fc | 1 | 2023 | 535 | 0.170 |
Why?
|
Blood Donors | 1 | 2021 | 345 | 0.170 |
Why?
|
Science | 1 | 2021 | 239 | 0.160 |
Why?
|
Eukaryotic Initiation Factor-2 | 1 | 2019 | 181 | 0.150 |
Why?
|
Proline | 1 | 2019 | 457 | 0.140 |
Why?
|
Research Personnel | 1 | 2021 | 588 | 0.140 |
Why?
|
Membrane Proteins | 1 | 2013 | 7858 | 0.130 |
Why?
|
Computer-Aided Design | 1 | 2015 | 300 | 0.110 |
Why?
|
Vacuoles | 1 | 2013 | 228 | 0.100 |
Why?
|
Antibodies, Protozoan | 2 | 2024 | 252 | 0.100 |
Why?
|
Antibodies, Neutralizing | 1 | 2021 | 1943 | 0.100 |
Why?
|
Molecular Structure | 1 | 2015 | 1880 | 0.090 |
Why?
|
Drug Design | 1 | 2015 | 1048 | 0.090 |
Why?
|
Structure-Activity Relationship | 1 | 2015 | 3076 | 0.080 |
Why?
|
Erythrocytes | 1 | 2015 | 2413 | 0.060 |
Why?
|
Models, Molecular | 1 | 2015 | 5439 | 0.060 |
Why?
|
Molecular Targeted Therapy | 1 | 2015 | 2811 | 0.060 |
Why?
|
Merozoite Surface Protein 1 | 1 | 2023 | 38 | 0.060 |
Why?
|
Physicians | 1 | 2021 | 4591 | 0.050 |
Why?
|
Merozoites | 1 | 2023 | 61 | 0.050 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2015 | 10766 | 0.050 |
Why?
|
HIV Seronegativity | 1 | 2024 | 211 | 0.050 |
Why?
|
Sequence Analysis, DNA | 1 | 2014 | 4740 | 0.050 |
Why?
|
Antigens, Protozoan | 1 | 2023 | 316 | 0.050 |
Why?
|
Humans | 10 | 2024 | 761572 | 0.050 |
Why?
|
Immunomodulation | 1 | 2023 | 549 | 0.040 |
Why?
|
Tanzania | 1 | 2024 | 1387 | 0.040 |
Why?
|
Adaptive Immunity | 1 | 2023 | 726 | 0.040 |
Why?
|
HIV Seropositivity | 1 | 2024 | 960 | 0.040 |
Why?
|
Genomics | 1 | 2014 | 5821 | 0.040 |
Why?
|
HIV Infections | 1 | 2024 | 17352 | 0.040 |
Why?
|
Genome-Wide Association Study | 1 | 2016 | 12690 | 0.040 |
Why?
|
Specialization | 1 | 2021 | 778 | 0.030 |
Why?
|
Disease Models, Animal | 1 | 2015 | 18253 | 0.030 |
Why?
|
Animals | 3 | 2023 | 168467 | 0.030 |
Why?
|
Autoantibodies | 1 | 2023 | 2116 | 0.030 |
Why?
|
Artemisinins | 1 | 2016 | 218 | 0.030 |
Why?
|
Interleukin-6 | 1 | 2023 | 3208 | 0.030 |
Why?
|
Time Factors | 1 | 2015 | 39970 | 0.030 |
Why?
|
Communicable Diseases | 1 | 2021 | 875 | 0.030 |
Why?
|
Middle Aged | 2 | 2024 | 220920 | 0.030 |
Why?
|
Genetics, Population | 1 | 2016 | 937 | 0.020 |
Why?
|
Immunoglobulin G | 1 | 2023 | 4544 | 0.020 |
Why?
|
Neutrophils | 1 | 2023 | 3767 | 0.020 |
Why?
|
Aged | 1 | 2023 | 169310 | 0.020 |
Why?
|
Mutation | 1 | 2014 | 30054 | 0.020 |
Why?
|
Mice | 1 | 2015 | 81533 | 0.020 |
Why?
|
Phosphorylation | 1 | 2019 | 8321 | 0.020 |
Why?
|
Male | 1 | 2023 | 360842 | 0.020 |
Why?
|
Female | 1 | 2023 | 392686 | 0.010 |
Why?
|
Child, Preschool | 1 | 2023 | 42230 | 0.010 |
Why?
|
Young Adult | 1 | 2024 | 59255 | 0.010 |
Why?
|
Signal Transduction | 1 | 2019 | 23447 | 0.010 |
Why?
|
Adolescent | 1 | 2024 | 88324 | 0.010 |
Why?
|
Child | 1 | 2023 | 80156 | 0.010 |
Why?
|
Adult | 1 | 2024 | 221203 | 0.010 |
Why?
|